Cure My Disease

Don't miss your cure!

 Log in / Sign up

One 2-Hour class may help new mothers manage Post-Cesarean pain

NCT ID NCT07832240

NEW Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Stanford researchers are testing whether a single 120-minute pain relief class called Empowered Relief can help women with severe pain after cesarean delivery. The class teaches pain education, relaxation, deep breathing, and cognitive behavioral skills, and participants receive access to a relaxation app. The study enrolls 60 postpartum women during their hospital stay and randomly assigns them to either the class plus standard care or standard care alone. Researchers follow participants for 12 weeks to see whether the class is feasible and acceptable to deliver during inpatient recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Empowered Relief, a single 120-minute pain relief skills class taught by certified instructors
What this could lead to
If it works, a single class could give women recovering from cesarean delivery practical skills to manage severe pain, possibly reducing reliance on pain medication.
What could go wrong
This is a small pilot study testing whether the class can even be delivered during a hospital stay. It may not show real pain relief, and results may not apply to all postpartum patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Complete informed consent. 2. Age 18 years or above. 3. Postpartum woman who delivered by cesarean within the Stanford Healthcare system. 4. Viable birth (singleton or multiple gestation). 5. All maternal demographics and complications are eligible: parity, medical conditions (e.g., pre-eclampsia, gestational diabetes), and post-surgical complications (e.g., hysterectomy, ICU admission, extended hospital stay), provided the participant is clinically able to complete the study intervention and procedures. 6. Currently hospitalized during the postpartum period following cesarean delivery. 7. Severe pain, defined as more than 2 pain scores \>6/10 on the numeric rating scale (NRS), following cesarean delivery. 8. English fluency, with ability to read and write. 9. Ability to adhere to and complete study procedures. 10. Access to a smart device if attending ER session via Zoom. Exclusion Criteria: 1. Age under 18 years. 2. Medical or clinical instability that, in the judgment of the treating or research team, would preclude safe participation in the study procedures and/or intervention. 3. Chronic pain prior to pregnancy. 4. Cognitive impairment or psychological factors that would preclude comprehension of study material or full participation. 5. Unable or unwilling to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute postoperative pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Chronic Pain chronic pain syndrome Pain Pain, Postoperative puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute postoperative pain Cesarean section complications Chronic pain Postpartum Severe pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Lucile Packard Children's Hospital Stanford

    Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.